Cellebrite DI Ltd. delivers specialized digital intelligence solutions crafted for legally authorized investigations. Their comprehensive DI platform enables users to efficiently gather, ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $0.09 · Revenue $145.89M · 5 analysts
Est. EPS $0.11 · Revenue $151.44M · 5 analysts
Est. EPS $0.28 · Revenue $556.65M · 5 analysts
Est. EPS $0.06 · Revenue $148.92M · 3 analysts
EPS $0.03 · Revenue $131.14M
EPS $0.04 · Revenue $128.30M
EPS $0.31 · Revenue $475.68M
EPS $0.08 · Revenue $126.03M
EPS $0.08 · Revenue $113.28M
EPS $0.07 · Revenue $107.55M
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $475.7M | +18.6% | +2.2% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $78.3M | +127.7% | -41.8% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +84.2% | -0.2% | -2.1% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | +14.0% | -1.5% | -18.2% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | +16.5% | +123.3% | -43.0% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $155.7M | +28.1% | -13.8% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | +32.7% | +8.1% | -15.7% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 4.7% | +43.4% | -3.4% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 1.56x | -18.9% | +4.8% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $938.9M | +36.0% | +4.4% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | 0.31 vs 0.33 | -6.2% | 0.03 vs 0.09 | -73.1% |
| Revenue Surprise | $475.7M vs $473.1M | +0.6% | $131.1M vs $145.9M | -10.1% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | Hogan Thomas E. | other: Advisor | Ordinary shares, par value NIS 0.00001 | D | 25,299 | $11.29 |
| Aug 24, 2026 | GEE DAVID NICHOLAS | officer: Chief Marketing Officer | Ordinary shares, par value NIS 0.00001 | D | 4,323 | $11.36 |
| Aug 21, 2026 | Jewell Marcus | officer: Global Chief Revenue Officer | Ordinary shares, par value NIS 0.00001 | D | 12,562 | $11.24 |
| Aug 21, 2026 | GEE DAVID NICHOLAS | officer: Chief Marketing Officer | Ordinary shares, par value NIS 0.00001 | D | 2,198 | $11.24 |
| Aug 12, 2026 | Hogan Thomas E. | director, officer: Chief Executive Officer | Ordinary shares, par value NIS 0.00001 | D | 139,713 | $15.39 |
Operator: Welcome to the Cellebrite Second Quarter 2026 Financial Results Conference Call. [Operator Instructions] I would now like to turn the call over to your first speaker today, Mr. Andrew Kramer. Mr. Kramer, the floor is yours. Andrew Kramer: Thank you very much, operator, and good morning, everybody. Welcome to Cellebrite's Second Quarter 2026 Financial Results Call. I'm joined this morning by our primary speakers, Adam Clammer, Cellebrite's Chairman of the Board; Shiv Ramji, Cellebrite's new CEO; and David Barter, Cellebrite's CFO. Shiv, Dave and Marcus Jewell, our CRO, will participate on our Q&A session. This call is being recorded, and a replay of the recording will be made available on our website shortly after the call, along with a copy of the transcript. Please note that today's press release and financial statements, including GAAP to non-GAAP reconciliations are available on the Investor Relations website at investors.cellebrite.com. In addition to the press release, we posted a separate investor presentation that provides an overview of the business and our recent financial performance. I'd like to remind everybody who's listening on the webcast that the slide in your webcast viewer is a placeholder only. There are no actual slides to accompany the prepared remarks. We also published our historical financial information and supplemental data for the first 2 quarters of 2026, each quarter of 2025, along with the full year 2024 and 2023 on our Investor Relations website. Additionally, unless stated otherwise, our discussion of our second quarter 2026 financial metrics as well as the financial metrics provided in our outlook will be done on a non-GAAP basis only, and all historical comparisons are with the comparable periods of 2025. I'd like to remind you that today's discussion will contain forward-looking statements, including, but not limited to, the company's business operations and financial performance. All forward-looking statements are subject to risks and uncertainties and other factors that could cause matters expressed or implied by those forward-looking statements not to occur. Actual results could also differ materially from historical results and/or from forecasts. Some of these forward-looking statements are discussed under the heading Risk Factors and elsewhere in the company's annual report on Form 20-F filed with the SEC on March 3, 2026. The company does not undertake to update any forward-looking statements to reflect future events or circumstances. And with all that being said, I'd now like to turn the call over to Adam Clammer. Adam Clammer: Thank you, Andy, and good morning, everyone. As you saw in this morning's release, our Board has appointed Shiv Ramji as Chief Executive Officer, effective today. Before I go further, I want to take a moment on behalf of the entire Board to thank Tom Hogan. Tom joined Cellebrite 3 years ago as Executive Chairman, and we're incredibly appreciative of his impact. Since …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Thomas E. Hogan | Chief Executive Officer & Director | USD 969,000 | Male | 1959 | Active |
Marcus Jewell | Global Chief Revenue Officer | USD 835,000 | Male | 1973 | Active |
David Nicholas Gee | Chief Marketing Officer | USD 499,000 | Male | 1967 | Active |
David Barter | Chief Financial Officer | USD 416,000 | Male | 1972 | Active |
Sigalit Shavit | Chief Information Officer | — | Female | 1968 | Active |
Zohar Tadmor-Eilat | Chief People Officer | — | Female | 1972 | Active |
Holly Windham | General Counsel & Chief Compliance Officer | — | Female | 1967 | Active |
Shiven Ramji | President of Products & Technology | — | Male | — | Active |
Andrew Kramer | Vice President of Investor Relations | — | — | — | Active |
Christopher Wade | Chief Technology Officer | — | Male | 1984 | Active |
New York, New York--(Newsfile Corp. - September 2, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Cellebrite offers ~90% recurring revenue and 117% net retention, anchored by mobile forensics leadership and new growth levers. Cellebrite is rated 'Buy' at ~$12, with a Fair Value estimate of $17.3, reflecting ~44% potential upside and a strong GARP profile. I see a narrow moat based on their leadership in mobile forensics, robust rule of X score, and cross-selling opportunities.
/PRNewswire/ -- Cellebrite (Nasdaq: CLBT), leader mondial des solutions d'investigation et de renseignement numériques basées sur l'IA pour les secteurs
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), líder mundial en soluciones de inteligencia e investigación digital basadas en IA para los sectores público
Independent assessment gives Australian law enforcement, defense and national security agencies a platform for collaborating and managing digital evidence in the cloud quickly and securely TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
